Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Suzhou Zelgen Biopharmaceuticals (688266)
- 104.00
- +3.60+3.59%
Market Closed Apr 30 15:00 CST
27.53BMarket Cap55.29P/E (TTM)
108.73High99.13Low5.58MlotVolume100.39Open100.40Prev Close579.90MTurnover2.11%Turnover RatioLossP/E (Static)264.71MShares134.1752wk High16.07P/B27.53BFloat Cap75.1052wk Low120.48Limit Up264.71MShs Float134.17Historical High80.32Limit Down9.56%Range %21.68Historical Low--Dividend TTM103.86Avg Price2.36MlotAsk--Div Yield TTM1Lot Size2.71MlotBid
Suzhou Zelgen Biopharmaceuticals (688266) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 388.17%942.97M | 62.92%893.84M | 59.68%625.94M | 63.21%384.68M | 86.21%193.16M | 27.42%548.64M | 22.93%391.99M | 4.42%235.69M | -8.81%103.74M | 36.26%430.57M |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | ---- | ---- | -87.46%10.48K | ---- | ---- | ---- |
| Cash received relating to other operating activities | 754.25%201.76M | -50.14%161.64M | -54.90%140.2M | -70.29%90.47M | -88.55%23.62M | 78.81%324.19M | 294.34%310.86M | 308.79%304.47M | 204.80%206.29M | 167.31%181.3M |
| Cash inflows from operating activities | 428.06%1.14B | 20.93%1.06B | 9.00%766.14M | -12.04%475.14M | -30.08%216.78M | 42.65%872.83M | 76.69%702.86M | 79.93%540.16M | 70.87%310.02M | 49.46%611.87M |
| Goods services cash paid | 66.96%11.6M | -24.50%42.08M | -47.79%24.89M | -38.69%13.81M | -12.06%6.95M | -10.48%55.73M | 46.66%47.67M | 12.64%22.53M | -33.05%7.9M | 195.82%62.26M |
| Staff behalf paid | 18.36%117.09M | 11.84%343.27M | 7.85%256.19M | 4.72%176.23M | 4.43%98.93M | 4.99%306.92M | 7.03%237.54M | 10.25%168.28M | 9.00%94.73M | 9.86%292.34M |
| All taxes paid | 41.99%17.79M | 57.23%80.56M | 27.61%51.28M | 14.50%31.75M | -29.33%12.53M | 227.06%51.24M | 167.16%40.18M | 238.66%27.73M | 1,053.01%17.73M | 94.82%15.67M |
| Cash paid relating to other operating activities | 53.72%160.83M | 46.97%618.36M | 44.94%450.52M | 29.33%270.37M | 3.96%104.63M | -11.30%420.74M | -13.06%310.83M | -17.39%209.06M | -9.98%100.64M | -2.10%474.36M |
| Cash outflows from operating activities | 37.79%307.32M | 29.91%1.08B | 23.05%782.88M | 15.10%492.16M | 0.92%223.03M | -1.18%834.62M | 1.47%636.22M | -1.45%427.61M | 4.22%221M | 8.32%844.62M |
| Net cash flows from operating activities | 13,491.88%837.41M | -175.34%-28.78M | -125.11%-16.73M | -115.12%-17.02M | -107.02%-6.25M | 116.41%38.2M | 129.08%66.65M | 184.17%112.55M | 390.88%89.02M | 37.15%-232.75M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 5,425.48%396.59M | -90.34%116.12M | -93.53%65.49M | -97.84%17.18M | -93.87%7.18M | -3.82%1.2B | 54.53%1.01B | 160.69%795.1M | -21.94%117.09M | 64.26%1.25B |
| Cash received from returns on investments | --31.65M | -34.67%9.71M | -90.34%451.33K | -95.34%194K | ---- | 19.49%14.86M | -12.94%4.67M | 90.12%4.16M | -74.57%229.93K | 86.72%12.44M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -35.00%2.6K |
| Cash inflows from investing activities | 5,866.49%428.24M | -89.66%125.83M | -93.52%65.94M | -97.83%17.37M | -93.88%7.18M | -3.59%1.22B | 53.98%1.02B | 160.18%799.26M | -22.25%117.32M | 64.45%1.26B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -0.03%33.8M | 89.64%181.47M | 102.56%132.5M | 57.30%79.72M | 11.85%33.81M | 52.86%95.69M | 52.76%65.41M | 62.91%50.68M | 48.17%30.23M | -29.36%62.6M |
| Cash paid to acquire investments | --999.45M | ---- | ---- | ---- | ---- | 161.37%2.97B | 34.71%943M | 1.86%713M | 96.59%403M | 20.35%1.14B |
| Cash outflows from investing activities | 2,956.23%1.03B | -94.07%181.47M | -86.86%132.5M | -89.56%79.72M | -92.20%33.81M | 155.69%3.06B | 35.75%1.01B | 4.45%763.68M | 92.20%433.23M | 16.08%1.2B |
| Net cash flows from investing activities | -2,171.87%-605.02M | 96.98%-55.63M | -887.13%-66.55M | -275.18%-62.34M | 91.57%-26.63M | -2,945.67%-1.85B | 110.25%8.46M | 108.40%35.59M | -324.05%-315.9M | 124.55%64.84M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | -99.97%339.65K | ---- | ---- | ---- | --1.19B |
| Cash from borrowing | -60.37%56M | -12.53%1.13B | -22.80%616.02M | -18.27%431.52M | -59.51%141.32M | 30.95%1.29B | 7.13%798M | 29.44%528M | 30.71%349M | 75.37%983.8M |
| Cash inflows from financing activities | -60.37%56M | -12.55%1.13B | -22.80%616.02M | -18.27%431.52M | -59.51%141.32M | -40.79%1.29B | -58.81%798M | -66.99%528M | 30.71%349M | 287.91%2.18B |
| Borrowing repayment | 24.63%201.9M | -11.01%1.01B | -33.53%507.07M | -31.21%317.07M | -33.06%162M | 80.13%1.13B | 78.64%762.8M | 142.58%460.9M | 61.33%242M | 170.85%630M |
| Dividend interest payment | -7.98%5.79M | 6.23%26.09M | 4.06%19.47M | -0.39%12.72M | 1.20%6.3M | 16.00%24.56M | 21.44%18.71M | 32.46%12.77M | 34.18%6.22M | 88.79%21.17M |
| Cash payments relating to other financing activities | 30.41%6.29M | -45.51%98.39M | -4.70%90.17M | 660.90%75.82M | -21.81%4.82M | 1,055.12%180.57M | 524.62%94.62M | -21.81%9.96M | -33.01%6.17M | -54.55%15.63M |
| Cash outflows from financing activities | 23.60%213.98M | -15.34%1.13B | -29.61%616.71M | -16.13%405.61M | -31.95%173.12M | 100.95%1.34B | 91.48%876.13M | 127.72%483.64M | 55.26%254.39M | 139.68%666.81M |
| Net cash flows from financing activities | -396.86%-157.98M | 85.38%-7.5M | 99.12%-685K | -41.59%25.91M | -133.61%-31.8M | -103.40%-51.32M | -105.28%-78.13M | -96.80%44.36M | -8.28%94.61M | 433.74%1.51B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -48,790.84%-4.5M | 69.96%-690.41K | 1.70%-527.6K | -1,325.23%-453.65K | -185.31%-9.21K | -1,160.56%-2.3M | -271.96%-536.72K | -91.08%37.03K | 105.24%10.8K | -94.67%216.72K |
| Net increase in cash and cash equivalents | 208.08%69.91M | 95.02%-92.61M | -2,273.64%-84.5M | -128.00%-53.9M | 51.09%-64.69M | -238.67%-1.86B | -100.30%-3.56M | -76.80%192.54M | -6,055.96%-132.25M | 486.05%1.34B |
| Add:Begin period cash and cash equivalents | -42.62%124.66M | -89.54%217.27M | -89.54%217.27M | -89.54%217.27M | -89.54%217.27M | 182.27%2.08B | 182.27%2.08B | 182.27%2.08B | 182.27%2.08B | -32.07%736.11M |
| End period cash equivalent | 27.52%194.57M | -42.62%124.66M | -93.60%132.77M | -92.80%163.36M | -92.16%152.58M | -89.54%217.27M | 8.91%2.07B | 44.96%2.27B | 165.07%1.95B | 182.27%2.08B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | ShinWing Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm